CATALOGO DEI PRODOTTI DELLA RICERCA

VIAPIANA, Ombretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.553
EU - Europa 14.294
AS - Asia 9.989
SA - Sud America 1.368
Continente sconosciuto - Info sul continente non disponibili 542
AF - Africa 314
OC - Oceania 23
Totale 43.083
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.117
RU - Federazione Russa 5.118
SG - Singapore 3.905
GB - Regno Unito 2.984
CN - Cina 2.921
IT - Italia 2.177
BR - Brasile 1.064
DE - Germania 913
VN - Vietnam 867
HK - Hong Kong 812
SE - Svezia 709
FR - Francia 679
IE - Irlanda 601
FI - Finlandia 416
BD - Bangladesh 305
KR - Corea 285
CA - Canada 225
IN - India 217
JP - Giappone 156
UA - Ucraina 154
TR - Turchia 135
AR - Argentina 108
PL - Polonia 94
MX - Messico 92
NL - Olanda 92
ES - Italia 75
NG - Nigeria 73
ID - Indonesia 72
ZA - Sudafrica 65
IQ - Iraq 57
AT - Austria 53
BE - Belgio 50
EC - Ecuador 48
VE - Venezuela 39
CO - Colombia 37
BJ - Benin 36
UZ - Uzbekistan 31
PK - Pakistan 29
CL - Cile 27
RO - Romania 24
CR - Costa Rica 22
MA - Marocco 22
SA - Arabia Saudita 22
EG - Egitto 21
TG - Togo 21
CH - Svizzera 20
JM - Giamaica 20
LT - Lituania 20
IR - Iran 19
PE - Perù 18
AU - Australia 17
KE - Kenya 17
AE - Emirati Arabi Uniti 16
MY - Malesia 16
IL - Israele 15
PH - Filippine 15
AZ - Azerbaigian 12
PY - Paraguay 12
CZ - Repubblica Ceca 10
DZ - Algeria 10
GR - Grecia 10
HN - Honduras 10
NP - Nepal 10
AL - Albania 9
BG - Bulgaria 9
DK - Danimarca 9
EE - Estonia 9
GT - Guatemala 9
HR - Croazia 9
PR - Porto Rico 9
TN - Tunisia 9
JO - Giordania 8
PT - Portogallo 8
SV - El Salvador 8
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
NI - Nicaragua 7
SN - Senegal 7
TH - Thailandia 7
AM - Armenia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
PA - Panama 6
QA - Qatar 6
UY - Uruguay 6
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BH - Bahrain 4
CI - Costa d'Avorio 4
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
LY - Libia 4
NO - Norvegia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
Totale 42.471
Salva come PNG Salva come JPEG
Città #
Southend 2.568
Ashburn 2.367
Singapore 2.082
Moscow 1.748
San Jose 1.663
Dallas 1.340
Chandler 1.336
Jacksonville 861
Hong Kong 796
Council Bluffs 632
Dublin 597
Beijing 507
Verona 490
Ann Arbor 474
Woodbridge 466
The Dalles 380
New York 360
Houston 321
Los Angeles 312
Ho Chi Minh City 269
Lawrence 232
Wilmington 232
Princeton 231
Jinan 221
Bologna 195
Redmond 194
Hanoi 186
Santa Clara 173
Shenyang 173
Nanjing 172
Milan 153
Munich 143
Buffalo 138
Tokyo 138
Helsinki 136
São Paulo 126
Hebei 104
Tianjin 104
Redondo Beach 102
Rome 85
Sindelfingen 84
Warsaw 80
London 78
Orem 77
Changsha 74
Zhengzhou 73
Abuja 70
Columbus 69
Ningbo 68
Haikou 67
Denver 66
Phoenix 65
Chicago 64
Toronto 60
Montreal 59
Brooklyn 58
Nanchang 58
Taizhou 58
Guangzhou 55
San Francisco 55
Hangzhou 54
Redwood City 54
Atlanta 52
Seattle 52
Falkenstein 50
Jiaxing 47
Brussels 45
Turku 45
Da Nang 44
Washington 44
Taiyuan 43
Boardman 39
Naples 39
Hyderabad 38
Johannesburg 38
Manchester 38
Boston 37
Cotonou 36
Mexico City 36
Norwalk 36
Poplar 36
Chennai 34
Frankfurt am Main 34
Stockholm 33
Rio de Janeiro 32
Vienna 32
Brasília 30
Fuzhou 30
Tashkent 29
Amsterdam 28
Düsseldorf 27
Fairfield 27
Haiphong 27
Jakarta 27
Lanzhou 26
McKinney 26
Dong Ket 25
Las Vegas 25
Mumbai 24
Falls Church 23
Totale 25.587
Salva come PNG Salva come JPEG
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 886
Teriparatide and denosumab combination therapy and skeletal metabolism 362
Artrite Reumatoide e Metabolismo Minerale 292
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 287
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 274
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 267
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 264
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 258
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 254
Anti-CCP antibodies and bone 253
Bone metabolism in patients with anorexia nervosa and amenorrhoea 242
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 240
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 237
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 234
[Risk factors for hip fracture in elderly persons]. 234
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 233
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 226
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 223
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 222
[Pathophysiology of osteoarthritis: perspectives] 220
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 219
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 218
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 217
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 216
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 215
Bone involvement and osteoporosis in mastocytosis. 215
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 214
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 212
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 211
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 209
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 209
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 209
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 206
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 204
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 199
Could γ\δ T-cells explain zoledronic acid adverse events? 198
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 198
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 198
Prevalence and incidence of rheumatoid arthritis in Italy. 197
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 195
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 193
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 192
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 191
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 191
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 190
Guidelines for the diagnosis, prevention and management of osteoporosis 190
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 189
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 189
Allergy and the bone: unexpected relationships 187
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 187
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 186
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 186
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 186
Osteopetrosi 185
The obesity paradox and osteoporosis 184
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 182
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 182
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 182
Bone Disease in Mastocytosis 181
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 179
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 179
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 178
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 178
Sclerostin and DKK1 in primary hyperparathyroidism. 176
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 176
DXA bone mineral density in males: retrospective study in real life. 175
Association between environmental air pollution and rheumatoid arthritis flares 175
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 175
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 174
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 174
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 173
Invecchiamento dell'apparato scheletrico 173
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 173
Prevalence of osteoporosis in patients affected by mastocytosis 173
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 173
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 172
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 172
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 171
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 171
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 170
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 169
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 169
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 169
Effects of denosumab on peripheral lymphocyte subpopulations 168
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 166
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 166
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 166
Artropatie degenerative 165
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 165
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 165
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 164
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 164
Safety issues and adverse reactions with osteoporosis management 163
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 162
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 161
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 161
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 160
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 160
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 160
Bone turnover markers in patients with osteogenesis imperfecta. 159
Totale 20.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.178
article - articoli 142.850
book - libri 0
conference - conferenze 712
curatela - curatele 0
other - altro 1.734
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.882
Totale 298.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.218 0 0 0 110 86 54 59 106 143 48 140 472
2022/20234.007 279 379 379 708 331 961 50 224 457 59 129 51
2023/20242.163 110 163 193 263 237 343 103 171 28 92 318 142
2024/20255.311 282 342 259 794 247 166 218 209 780 418 529 1.067
2025/202617.896 1.194 881 1.290 3.020 4.501 1.184 1.631 973 1.259 897 378 688
2026/20273.129 300 501 683 1.645 0 0 0 0 0 0 0 0
Totale 43.083